A clinical trial testing muvalaplin, a novel oral medication, was able to safely and effectively lower high levels of lipoprotein (a), according to late-breaking science presented today at the ...
The survey of more than 1,500 Canadians conducted by Leger in August 2024 delivers insights and comparisons to Sodexo’s International Sustainable Food Barometer survey conducted by Harris Interactive.